| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antithrombotic Effects of BCH 2763, a New Direct Thrombin Inhibitor, in a Canine Model of Venous Thrombosis
|
Thomas B. McClanahan
|
|
1999
|
7 |
3 |
p. 301-306
6 p.
|
artikel
|
| 2 |
Antithrombotic Effects of BCH 2763, a New Direct Thrombin Inhibitor, in a Canine Model of Venous Thrombosis
|
McClanahan, Thomas B.
|
|
1999
|
7 |
3 |
p. 301-306
|
artikel
|
| 3 |
Aspirin and Ticlopidine After Routine Coronary Stenting: The Gold Standard as of 1999
|
Peter A. McCullough
|
|
1999
|
7 |
3 |
p. 233-239
7 p.
|
artikel
|
| 4 |
Aspirin and Ticlopidine After Routine Coronary Stenting: The Gold Standard as of 1999
|
McCullough, Peter A.
|
|
1999
|
7 |
3 |
p. 233-239
|
artikel
|
| 5 |
Clopidogrel with Aspirin Is the Optimal Antiplatelet Regimen for Intracoronary Stenting
|
Steven R. Steinhubl
|
|
1999
|
7 |
3 |
p. 227-231
5 p.
|
artikel
|
| 6 |
Clopidogrel with Aspirin Is the Optimal Antiplatelet Regimen for Intracoronary Stenting
|
Steinhubl, Steven R.
|
|
1999
|
7 |
3 |
p. 227-231
|
artikel
|
| 7 |
Efficacy of Abciximab Induced Platelet Blockade Using a Rapid Point of Care Assay
|
Dean J. Kereiakes
|
|
1999
|
7 |
3 |
p. 265-276
12 p.
|
artikel
|
| 8 |
Efficacy of Abciximab Induced Platelet Blockade Using a Rapid Point of Care Assay
|
Kereiakes, Dean J.
|
|
1999
|
7 |
3 |
p. 265-276
|
artikel
|
| 9 |
Emerging Treatment of Acute Coronary Syndromes with Platelet Glycoprotein IIBIIIA Inhibitors
|
Matthew T. Roe
|
|
1999
|
7 |
3 |
p. 247-257
11 p.
|
artikel
|
| 10 |
Emerging Treatment of Acute Coronary Syndromes with Platelet Glycoprotein IIB/IIIA Inhibitors
|
Roe, Matthew T.
|
|
1999
|
7 |
3 |
p. 247-257
|
artikel
|
| 11 |
Glycoprotein IIbIIIa Receptor Inhibition in Interventional Cardiology
|
C. Michael Gibson
|
|
1999
|
7 |
3 |
p. 287-302
16 p.
|
artikel
|
| 12 |
Glycoprotein IIb/IIIa Receptor Inhibition in Interventional Cardiology
|
Gibson, C. Michael
|
|
1999
|
7 |
3 |
p. 287-302
|
artikel
|
| 13 |
Hemostatic Effects of 1 mg Daily Warfarin on Post CABG Patients
|
Jeanine M. Walenga
|
|
1999
|
7 |
3 |
p. 313-318
6 p.
|
artikel
|
| 14 |
Hemostatic Effects of 1 mg Daily Warfarin on Post CABG Patients
|
Walenga, Jeanine M.
|
|
1999
|
7 |
3 |
p. 313-318
|
artikel
|
| 15 |
Heparin Induced Thrombocytopenia: Diagnosis and Contemporary Antithrombin Management
|
James L. Januzzi, Jr.
|
|
1999
|
7 |
3 |
p. 259-264
6 p.
|
artikel
|
| 16 |
Heparin Induced Thrombocytopenia: Diagnosis and Contemporary Antithrombin Management
|
Januzzi, James L.
|
|
1999
|
7 |
3 |
p. 259-264
|
artikel
|
| 17 |
Low Molecular Weight Heparins in the Cardiac Catheterization Laboratory
|
Gilles Montalescot
|
|
1999
|
7 |
3 |
p. 319-323
5 p.
|
artikel
|
| 18 |
Low Molecular Weight Heparins in the Cardiac Catheterization Laboratory
|
Montalescot, Gilles
|
|
1999
|
7 |
3 |
p. 319-323
|
artikel
|
| 19 |
New Thrombolytic Strategy: Bolus Administration of tPA and Urokinase-Fibrinogen Conjugate
|
Alexander V. Maksimenko
|
|
1999
|
7 |
3 |
p. 307-312
6 p.
|
artikel
|
| 20 |
New Thrombolytic Strategy: Bolus Administration of tPA and Urokinase-Fibrinogen Conjugate
|
Maksimenko, Alexander V.
|
|
1999
|
7 |
3 |
p. 307-312
|
artikel
|
| 21 |
Plasmin Activation System in Restenosis: Role in Pathogenesis and Clinical Prediction?
|
Gunter Christ
|
|
1999
|
7 |
3 |
p. 277-285
9 p.
|
artikel
|
| 22 |
Plasmin Activation System in Restenosis: Role in Pathogenesis and Clinical Prediction?
|
Christ, Gunter
|
|
1999
|
7 |
3 |
p. 277-285
|
artikel
|
| 23 |
Use of Glycoprotein IIbIIIa Inhibition Plus Fibrinolysis in Acute Myocardial Infarction
|
Michael P. Hudson
|
|
1999
|
7 |
3 |
p. 241-245
5 p.
|
artikel
|
| 24 |
Use of Glycoprotein IIb/IIIa Inhibition Plus Fibrinolysis in Acute Myocardial Infarction
|
Hudson, Michael P.
|
|
1999
|
7 |
3 |
p. 241-245
|
artikel
|
Tijdschrift beschrijving